Bioequivalence Study of Two 50 mg Desvenlafaxine Extended Release Formulations: A Randomized, Single-Dose, Open-Label, Two Periods, Crossover Study
Keyword(s):
2019 ◽
Vol 57
(08)
◽
pp. 408-415
Keyword(s):
Keyword(s):
2011 ◽
Vol 33
(6)
◽
pp. 738-745
◽
2010 ◽
Vol 32
(12)
◽
pp. 2088-2096
◽
Keyword(s):
Keyword(s):
Keyword(s):
2008 ◽
Vol 30
(10)
◽
pp. 1831-1843
◽